Polycystic ovary syndrome and weight management
Polycystic ovary syndrome and weight management
PCOS symptoms, diagnosis, insulin resistance, fertility, treatment and evidence-based weight-management options.
What is polycystic ovary syndrome?
Polycystic ovary syndrome (PCOS) is a common endocrine and reproductive disorder involving ovulatory dysfunction, androgen excess and characteristic ovarian findings after other causes are excluded. Not every patient has ovarian cysts, and PCOS occurs across body sizes.
Common features
Menstrual and fertility
Irregular or absent periods, unpredictable ovulation and difficulty conceiving.
Androgen symptoms
Excess facial or body hair, acne and scalp hair thinning.
Metabolic risk
Insulin resistance, prediabetes, type 2 diabetes, abnormal lipids and fatty liver are more common.
Sleep and mental health
Sleep apnea, depression, anxiety and eating disorders deserve screening.
Diagnosis and evaluation
Diagnosis is based on a combination of ovulatory dysfunction, clinical or biochemical hyperandrogenism and polycystic ovarian morphology, with age-appropriate criteria and exclusion of pregnancy, thyroid disease, elevated prolactin, nonclassic congenital adrenal hyperplasia and other causes. An ultrasound is not always required.
Treatment depends on the goal
| Goal | Possible approaches | Important consideration |
|---|---|---|
| Cycle control and endometrial protection | Hormonal contraception or periodic progestin | Individual contraindications matter |
| Fertility | Ovulation-induction therapy and reproductive referral | Weight treatment may help but should not delay appropriate fertility care |
| Metabolic health | Nutrition, activity, sleep, metformin and weight treatment | Screen glucose and cardiovascular risk |
| Androgen symptoms | Hormonal therapy, antiandrogens and cosmetic approaches | Reliable contraception may be required |
PCOS and weight management
A modest sustained loss can improve metabolic health and sometimes cycle regularity in patients with higher weight, but weight loss is not a cure and should not be a prerequisite for respectful PCOS care. Anti-obesity medication may be considered using standard eligibility and reproductive-safety principles.
How W8MD can help
W8MD physicians and clinicians evaluate weight history, medications, nutrition, body composition, metabolic risk factors and sleep-related barriers before recommending an individualized plan. Available services may include medical weight loss, GLP-1 treatment evaluation, established oral medications, nutrition planning, sleep-apnea care and long-term maintenance support.
When an FDA-approved medication is appropriate and insurance coverage exists, W8MD can review benefits and assist with prior-authorization documentation. Coverage and approval are determined by the health plan.
W8MD can evaluate weight and insulin-resistance factors, review medications, screen for sleep apnea, coordinate laboratory assessment and provide nutrition or prescription weight treatment when appropriate. Pregnancy plans and contraception are addressed before GLP-1 or other anti-obesity therapy.
Frequently asked questions
Do ovarian cysts prove PCOS?
No. Polycystic-appearing ovaries can occur without the syndrome, and PCOS can be diagnosed without visible cysts.
Can lean people have PCOS?
Yes. Body size does not exclude PCOS or its metabolic risks.
Are GLP-1 drugs FDA-approved specifically for PCOS?
No. They may be used for an approved obesity or diabetes indication in a patient who also has PCOS.
Authoritative sources
Request a PCOS and metabolic-health evaluation
W8MD Weight Loss, Sleep & MedSpa provides physician-supervised care in Brooklyn, New York and Northeast Philadelphia. Telehealth may be available for eligible patients based on location and applicable requirements.
Contact W8MD
